CDSCO monthly lab alert
CDSCO NSQ alert, December 2025: 175 drug batches flagged
By Blacklisted editorial team· Published 20 Jan 2026· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its December 2025 alert, the Central Drugs Standard Control Organisation listed 175 drug batches that failed quality tests, 71 at central laboratories and 104 at state drug-testing laboratories, from 139 manufacturers across 133 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Albendazole Tablets IP 400 mg, Sorbitol Solution 70% IP (Non-Crystallizing), Piperacillin and Tazobactam Injection I.P. 4.5 gm.
175
Batches flagged
71 / 104
Central / state labs
Assay
Top reason
139
Manufacturers
Batches per month, last 12 alerts
Jan 2025Dec 2025 · 175
Full list of NSQ batches, December 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Zinc Sulphate Dispersible Tablets I.P. | Batch MT10502Mfg Jun 2025 · Exp May 2027 | McW Healthcare (P) Ltd. 286Madhya Pradesh | the sample does not conforms to claim as per IP 2022 in respect to the uniformity of Dispersion & Disintegrstion testUniformity of weight/content | DTL BaddiState lab |
| X-Plus Gold | Batch VBX-044Mfg Jun 2025 · Exp May 2028 | Vaidban Ayurved BhawanHaryana | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of TadalafilOther | RDTL, ChandigarhCDSCO lab |
| Voglibose Tablets IP Vobil 0.2 Tables | Batch T-2404094Mfg Apr 2024 · Exp Mar 2026 | Oscar House | DescriptionDescription | FDAL, MumbaiState lab |
| Vildagliptin and Metformin Tablets IP | Batch VMHT1315Mfg May 2025 · Exp Apr 2027 | Unicure India Ltd. C-21Uttar Pradesh | The sample received does not conform to I.P. 2022 with respect to Assay and Dissolution.Assay | CDTL, MumbaiCDSCO lab |
| Tigecycline Injection IP 50 mg Tigelite Injection 50mg) | Batch LAA139Mfg Mar 2025 · Exp Feb 2027 | Lyka Labs LtdGujarat | The sample does not conform to I.P. 2022 with respect to test for Related substances.Related substances | CDTL, MumbaiCDSCO lab |
| Terbutaline Sulphate, Bromhexine Hydrochloride Guaiphenesin & Menthol Syrup(Cofflet Syrup) | Batch SCFL-2504Mfg Oct 2025 · Exp Mar 2027 | Heal (India) Laboratories Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Telmisartan Tablets IP 40mg Savtel 40 Tablets | Batch PT- 40584Mfg Feb 2024 · Exp Jan 2026 | Pharmaroots HealthcareHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Telmisartan.Dissolution | RDTL, GuwahatiCDSCO lab |
| Telmisartan Tablets IP 40mg | Batch 493TTF020Mfg Aug 2025 · Exp Jul 2027 | Swiss Garnier Life SciencesHimachal Pradesh | Sample fails the test Dissolution.Dissolution | RDTL Ernakulam,KeralaState lab |
| Telmisartan Tablets IP 40MG | Batch TEP25123ALMfg May 2025 · Exp Apr 2027 | Hindustan Laboratories LimitedMaharashtra | The sample does not confirm to IP 2022 requirement with respect to Dissolution TestDissolution | DTL,Dalgate Srinagar Kashmir (J & K)State lab |
| Telmisartan Tablets IP 40 mg | Batch BPLT-24205Mfg Aug 2024 · Exp Jul 2026 | Bennet Pharmaceuticals LtdHimachal Pradesh | Dissolution, Uniformity of content (Telmisartan)Dissolution | SDTL, GuwahatiState lab |
| Telmisartan Tablets IP | Batch 24305Mfg Oct 2024 · Exp Sep 2026 | Bennet Pharmaceuticals LtdHimachal Pradesh | The sample is not of standard quality for The reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Telmisartan Tablets I.P. 40 mg | Batch GT-2503Mfg Mar 2025 · Exp Feb 2027 | Helax Health Care Pvt. LtdUttarakhand | The sample does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab |
| TELTAN-MT 25 | Batch 2507017Mfg Jul 2025 · Exp Jun 2027 | Santus Global Formulations LimitedHimachal Pradesh | The sample does not conform to I.P w.r.t the test for Disintegration TestDisintegration | DTL,Dalgate Srinagar Kashmir ( J & K)State lab |
| Sorbitol Solution 70% IP (Non-Crystallizing) | Batch KA/017Mfg Aug 2025 · Exp Jul 2030 | Gujarat Ambuja Exports LtdGujarat | The sample received does not conform to I.P. 2022 specification with respect to The content of ethylene glycol impurity, which is exceeding permissible limitOther | CDTL-HyderabadCDSCO lab |
| Sorbitol Solution 70% IP (Non-Crystallizing) | Batch KA/017Mfg Aug 2025 · Exp Aug 2030 | Gujarat Ambuja Exports LtdGujarat | The sample does not conform to I.P. 2022 specification with respect to the content of ethylene glycol impurity, which is exceeding permissible limitOther | CDTL-HyderabadCDSCO lab |
| Sorbitol Solution 70% IP (Non-Crystallizing) | Batch KA/018Mfg Sep 2025 · Exp Aug 2030 | Gujarat Ambuja Exports LtdGujarat | The sample received does not conform to I.P. 2022 specification with respect to The content of ethylene glycol impurity, which is exceeding permissible limitOther | CDTL-HyderabadCDSCO lab |
| Sorbitol Solution 70% IP Non Crystallizing | Batch 2526010Mfg May 2025 · Exp Apr 2030 | Gujarat Ambuja Exports LtdGujarat | The sample does not conform to as Per IP in respect to The test for angle of Rotation.Other | CDTL, ChennaiCDSCO lab |
| Salbutamol Syrup IP | Batch SVK 25040Mfg Jul 2025 · Exp Jun 2027 | Labinduss LtdKerala | Sample fails the test pH as per IP.pH | RDTL Ernakulam,KeralaState lab |
| Safe Hand Gloves | Batch SHR0306Mfg Jun 2021 · Exp Jul 2026 | Nm | SURGICAL GLOVESOther | DTL BaddiState lab |
| Ranitidine Oral Solution IP ZALTAC Syrup | Batch MDL-C490Mfg Aug 2025 · Exp Jul 2027 | Marvellon Pharmaceuticals Pvt. Ltd. Kh. No. 114Himachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to The test pH and Assay of Ranitidine Hydrochloride calculated as Ranitidine.Assay | RDTL, ChandigarhCDSCO lab |
| Rabeprazole Sodium and Domperidone Sustained Release Capsules RABILITE-DSR | Batch B20824002Mfg Feb 2024 · Exp Jan 2026 | Torque Pharmaceuticals Pvt. Ltd 13B-14 | The sample does not conform to Manufacturers Specification with respect to The test of Dissolution of Rabeprazole Sodium (Acid Resistance in 0.1M HCl).Dissolution | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium Injection IP | Batch MD24G42Mfg Jul 2024 · Exp Jun 2026 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. with respect to The tests of Description, Clarity of Solution, Particulate Matter, pH, Related Substances and Assay of Rabeprazole Sodium.Assay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules RABIVO-DSR | Batch CG25-0039PMfg Feb 2025 · Exp Jan 2027 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample does not conform to claim with respect to The Assay of Rabeprazole Sodium.Assay | CDL, KolkataCDSCO lab |
| RYLES TUBE 12-FG (STERILE) | Batch BRT-002Mfg Jul 2024 · Exp Jun 2026 | Bhagwati Medicare DevicesGujarat | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of SterilitySterility | RDTL, ChandigarhCDSCO lab |
| Quinine Sulphate Tablets IP 300mg | Batch TA25530Mfg Jun 2025 · Exp May 2027 | Saintlife Pharmaceuticals LtdUttarakhand | The sample does not conform to the IP with respect to in Dissolution.Dissolution | DTL JaipurState lab |
| Propoxur Sulphanilamide Cetrimide Powder | Batch EE-240604Mfg Jun 2024 · Exp May 2026 | Ethicare Laboratories | The sample does no contorms to the claim with respect to Assay of PropoxurAssay | DTL UdaipurState lab |
| Progesterone Sustained Release Tablets 300 mg OPTOGEST 300 SR | Batch T2B15001Mfg Feb 2025 · Exp Jan 2027 | Synokem Pharmaceuticals Ltd. No.56-57Uttarakhand | The sample does not conform to claim as per Manufacturer Specification with respect to test for Dissolution.Dissolution | CDL, KolkataCDSCO lab |
| Primaquine Phosphate Tablets IP 2.5 mg | Batch T-1909Mfg Jun 2024 · Exp May 2026 | Jackson Laboratories Pvt. Ltd. Majitha RoadPunjab | The sample does not conform to claim as per I.P. 2022 with respect to The test for Assay and Dissolution of Primaquine.Assay | RDTL, GuwahatiCDSCO lab |
| Pregabaline & Nortriptyline Tablets (DGABA-N Tablets,) | Batch VGT242301BMfg Nov 2024 · Exp Oct 2026 | Vrindavan GlobalHimachal Pradesh | Misbranded.Misbranded | DCL TelanganaState lab |
| Prednisolone Tablets IP 20mg(Prednimeg-20) | Batch ZRST-2403Mfg May 2025 · Exp Apr 2027 | ZRS Pharmaceuticals India Pvt. Ltd | Incorrect labellingLabelling | DTL, PuducherryState lab |
| Prednisolone Sodium Phosphate Drops Reslone (Drops 10ml) | Batch L-250705Mfg Jul 2025 · Exp Jun 2027 | Dr. Pal'S Pharmaceuticals 10B-1Uttarakhand | The sample received does not conform with respect to The test for weight per ml.Weight | CDTL, MumbaiCDSCO lab |
| Polymeg 200, | Batch INTK038722Mfg Aug 2025 · Exp Aug 2028 | Clariant IGL Specialty Chemicals Pvt. LtdUttarakhand | The sample received does not conform to U.S.P. specification with respect to The content of diethylene glycol impurity, which is exceeding permissible limitOther | CDTL-HyderabadCDSCO lab |
| Poly Ethylene Glycol - 200, | Batch 43029642Mfg Feb 2025 · Exp Jan 2027 | Saudi Basic Industries Corporation (SABIC) | The sample received does not conform to U.S.P. specification with respect to The content of ethylene glycol and diethylene glycol impurities, which are exceeding permissible limitOther | CDTL-HyderabadCDSCO lab |
| Piperacillin and Tazobactam Injection I.P. 4.5 gm | Batch 325-1088Mfg Aug 2025 · Exp Jul 2027 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to The Test of Particulate matterParticulate matter | RDTL, ChandigarhCDSCO lab |
| Piperacillin and Tazobactam Injection I.P. 4.5 gm | Batch 325-1090Mfg Aug 2025 · Exp Jul 2027 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to The Test of Particulate matter.Particulate matter | RDTL, ChandigarhCDSCO lab |
| Phenylephrine Hydrochloride, Chlorpheniramine Maleate Qr-Cold Syrup | Batch WDLB012Mfg Jun 2025 · Exp May 2027 | Westerlin Drugs Pvt. Ltd. Industrial Area Fatuha (Patna) - 803201Bihar | The sample does not conform to I.P. with respect to The Assay of Phenylephrine Hydrochloride.Assay | CDL, KolkataCDSCO lab |
| Phenylephrine Hydrochloride & Chlorpheniramine Maleate, Syrup IP(Ryminic Syrup) | Batch BHCI284Mfg Jun 2025 · Exp May 2028 | Baseman Healthcare Inc | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Phenylephrine Hcl, Chlorpheniramine Maleate, Dextromethorphan Hbr Syrup (Pediacold DM) | Batch BHCI 276Mfg Mar 2025 · Exp Feb 2028 | Baseman Healthcare Inc | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate And Sodium Citrate Suspension((Ronikold - 250 Suspension)) | Batch MMR-543Mfg Aug 2024 · Exp Jul 2026 | Mediguard Remedies | Failed Assay (for Phenylephrine Hydrochloride IP)Assay | DTL, PuducherryState lab |
| Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Drops SINUS DROPS | Batch 876/26Mfg Apr 2025 · Exp Mar 2027 | Livin FormulationsTelangana | The sample received does not conform to manufacturer specification with respect to The test for pH only.pH | CDTL-HyderabadCDSCO lab |
| Paracetamol Tablets IP 650mg | Batch PCT25057Mfg Apr 2025 · Exp Mar 2027 | Vivek Pharmachem (India) Ltd. NH-8Rajasthan | The sample received does not conform to as per IP in respect to The test for Dissolution.Dissolution | CDTL, ChennaiCDSCO lab |
| Paracetamol Tablets IP 650 mg Arvimol 650 Tablets | Batch 24I-T1956EMfg Dec 2024 · Exp Nov 2026 | Orison Pharma International KhariHimachal Pradesh | The sample is not of standard quality for The reason stated under Description of The tablets.Description | RDTL, GuwahatiCDSCO lab |
| Paracetamol Tablets IP 500 mg | Batch SKTC25002Mfg Sep 2025 · Exp Aug 2027 | Gidsha PharmaceuticalsGujarat | Assay of ofloxacinAssay | DTL BaddiState lab |
| Paracetamol Tablets IP 500 mg | Batch PCT-2445Mfg Oct 2024 · Exp Mar 2027 | Suprex Laboratories | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Paracetamol.Dissolution | RDTL, GuwahatiCDSCO lab |
| Paracetamol Tablet IP 500mg | Batch PCT1203Mfg Aug 2024 · Exp Jul 2026 | Unicures India Ltd.C-21Uttar Pradesh | The sample does not conform to the I.P. with respect to Dissolution of Paracetamol.Dissolution | DTL JodhpurState lab |
| Pantoremed-40 Tables | Batch AMT-0892AMfg Oct 2024 · Exp Sep 2026 | Avalon Medicines Pvt. LtdHaryana | The sample does not comply with IP requrements for Dissolution Test at Acid StageDissolution | FDAL, MumbaiState lab |
| Pantoprazole Gastro-Residtant Tablets IP 40 mg (Ptcid 40 Tablets) | Batch BHA250196DMfg Feb 2025 · Exp Jan 2027 | Bionial Healthcare Pvt.LtdPunjab | Dissolution and DescriptionDissolution | DCL TelanganaState lab |
| Oral Rehydration Salts IP | Batch OE50244Mfg Sep 2025 · Exp Feb 2027 | Caplet India Pvt.Ltd. RekjuaniWest Bengal | The sample does not conform to I.P. with respect to Uniformity of weight, Seal test and also for The reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Ondansetron and Ranitidine HCI Injection Vomibac R Injection | Batch 110525Mfg May 2025 · Exp Apr 2027 | Pharma Chemico Laboratories DevghatHimachal Pradesh | The sample received does not conform to manufacturer specification with respect to The test for pH only.pH | CDTL-HyderabadCDSCO lab |
| Ondansetron Tablets IP Anset Tablets | Batch RBMT-921Mfg Sep 2025 · Exp Aug 2028 | Ronald Pharmaceuticals (P) Ltd. B.No. 740-AGujarat | The sample does not conform to I.P. 2022 with respect to The test for Related substances.Related substances | CDTL, MumbaiCDSCO lab |
| Ondanserton orally disintergratin tablets IP 40mg (Ondifil Tabelts) | Batch GT3C15Mfg Mar 2024 · Exp Feb 2026 | Ritual Drugs Pvt. LtdHaryana | The sample does not comply with IP requirement for Dissolution and Disintegration.Dissolution | FDAL, MumbaiState lab |
| Omeprazole Capsules 40 mg | Batch JDC-1452Mfg Oct 2024 · Exp Sep 2026 | Jpee DrugsUttarakhand | The sample does not conform to claim as per I.P. 2022 in respect to The Test of Dissolution (Acid Stage), Dissolution (Buffer Stage)Dissolution | CDL, KolkataCDSCO lab |
| Olmesartan Medoxomil Tablets IP 40 mg OLMESON-40 | Batch T-6585Mfg Jul 2025 · Exp Jul 2027 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample received does not conform to I.P. 2022, I.P. addendum 2024 specification with respect to The test for Dissolution only.Dissolution | CDTL-HyderabadCDSCO lab |
| Olmesartan Medoxomil Tablets IP 20mg | Batch GT250287Mfg Feb 2025 · Exp Jan 2027 | Theon Pharmaceuticals LtdHimachal Pradesh | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL Thiruvananthapuram,KeralaState lab |
| Ofloxacin, Ornidazole(Hyflox-OZ) | Batch OZ004-24Mfg Apr 2024 · Exp Mar 2026 | Harihar Pharmaceuticals Pvt. Ltd. SBP Road | Dissolution testDissolution | SDT&RL, BhubaneswarState lab |
| Ofloxacin Tablets I.P. 400 mg | Batch OFB-506Mfg Mar 2023 · Exp Feb 2026 | Healers Lab Unit IIHimachal Pradesh | Dissolution testDissolution | SDT&RL, BhubaneswarState lab |
| New unsyn Tablets Acetyl Salicyclic Acid BP 150mg Paracetamol BP 150mg, Caffeine (Anhydrous) BP 25mg Tablets | Batch 63Mfg Aug 2023 · Exp Jul 2026 | National Pharmacetutical G-18/1Maharashtra | DescriptionDescription | FDAL, MumbaiState lab |
| Neosorb 70/70B-Sirop De Sorbitol (Sorbitol Liquid, Crystallising USP/NF) | Batch 599646Mfg Mar 2023 · Exp Mar 2028 | Roquette Freres | The sample received does not conform to as per IP in respect to The test for angle of Rotation only.Other | CDTL, ChennaiCDSCO lab |
| My Young Model Foundation | Batch 6Mfg Apr 2025 · Exp Mar 2028 | Sidhi Vinayak CoDelhi | Test For Suspended SolidsOther | Government of NCT of DelhiState lab |
| Montelukast Sodium & Levocetirizine Hydrochloride Dispersible Tablets, (CIVIKAST-LC KID) | Batch GT240841Mfg Apr 2024 · Exp Mar 2026 | Theon Pharmaceuticals LtdHimachal Pradesh | The sample does not conform to Schedule V of Drugs Rules 1940 with respect to the test Disintegration as per IPDisintegration | DTL Thrissur,KeralaState lab |
| Metoprolol Succinate Prolonged Release Tablets IP Metloc ER50 | Batch MER3 294DMfg Nov 2024 · Exp Oct 2026 | Pulse Pharmaceuticals Pvt. LtdUttarakhand | The sample is not of standard quality for The reasons stated under DescriptionDescription | CDTL -IndoreCDSCO lab |
| Methycoblamin Oral Disintegrating Tablets 1500 mcg (MecoNeuron OD) | Batch MOD1085DMfg Jul 2025 · Exp Jun 2027 | Pulse Pharmaceuticals Pvt. LtdUttarakhand | Description and Uniformity of DispersionDescription | SDTL, PunjabState lab |
| Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP,(Ajapride M2) | Batch NHD24148AMfg Mar 2024 · Exp Feb 2027 | Nest Healthcare Pvt.LtdGujarat | Sample fails the test Descriptive Part for the tablets as per IP.Other | DTL Thiruvananthapuram,KeralaState lab |
| Menadione Sodium Bisulphite Injection IP Kaytin MB 1ml | Batch MA25D33Mfg Apr 2025 · Exp Mar 2027 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample received does not conform to The I.P. with respect to The test for Assay of Menadione Sodium BisulphiteAssay | CDTL, MumbaiCDSCO lab |
| Luliitech Cream | Batch DF200Mfg Apr 2024 · Exp Mar 2026 | Hygieia Home And Personal Care Solution | Assay and MisbrandedAssay | FDAL, MumbaiState lab |
| Luliconazole Lotion IP 1% W/V LUZORAN Lotion 30ml | Batch R09GE2518BMfg Sep 2025 · Exp Aug 2027 | Rednex Pharmaceuticals Pvt. LtdKerala | The sample received does not conform to I.P. 2022 with respect to The test for Related substance.Related substances | CDTL, MumbaiCDSCO lab |
| Lorazepam Injection IP 2 mg/ml, 2 ml WELOR | Batch WALV24001AMfg Oct 2024 · Exp Mar 2026 | Welcure Remedies Nahan RoadHimachal Pradesh | The sample does not conform to I.P. with respect to test for Particulate matter, Assay and is also not of standard quality for The reason stated under Description.Assay | CDL, KolkataCDSCO lab |
| Loratadine Ambroxol HCI, Guaiphenesin and Menthol Syrup | Batch REN027Mfg Nov 2024 · Exp Oct 2026 | Enicar Pharmaceutical Pvt. Ltd. J-214Maharashtra | The sample does not conform to the claim witm respect to Assay of Menthol and colourAssay | DTL, JaipurState lab |
| Levosalbutamol, Guaiphenesin And Ambroxol Syrup(BRETHNOL EXPECTORANT) | Batch BEL 6003Mfg Dec 2024 · Exp Nov 2026 | Bangalore Antibiotics and Biologicals Pvt LtdKarnataka | pHpH | DTL, PuducherryState lab |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup (Ambroflex-LS Syrup) | Batch AFG-2502Mfg May 2025 · Exp Apr 2027 | Apple Formulations Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup STUQOF-LS | Batch TS-538Mfg Jul 2025 · Exp Jun 2027 | Trimedix Pharma (P) Ltd. C-40Punjab | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Levosalbutamol Sulphate calculated as LevosalbutamolAssay | RDTL, ChandigarhCDSCO lab |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup AMBROX-LG | Batch TS-249Mfg Apr 2025 · Exp Mar 2027 | Trimedix Pharma (P) Ltd. C-40Punjab | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Levosalbutamol Sulphate calculated as LevosalbutamolAssay | RDTL, ChandigarhCDSCO lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup(Cafact-LS) | Batch EPL-043Mfg Sep 2025 · Exp Aug 2027 | Elixia pharmaceuticals | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup(Coffix-LS) | Batch ASL25019Mfg Apr 2025 · Exp Mar 2027 | Res SanctaHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup(Broxin-SB Expectorant) | Batch LA5029AMfg Jan 2025 · Exp Dec 2026 | Navkar LifesciencesHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup(Brolin Syrup) | Batch ECL/24/904Mfg Mar 2025 · Exp Feb 2027 | Emmchak Formulations Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levocetirizine Hydrochloride and Montelukast Sodium Tablets IP | Batch TA250025Mfg Jan 2025 · Exp Dec 2026 | Orchid Medlife Pvt. LtdHimachal Pradesh | Dissolution (Montelukast Sodium)Dissolution | SDTL, GuwahatiState lab |
| Levocetirizine Hydrochloride & Montelukast Sodium Tablets IP (Alticet-M) | Batch UGT-24842BMfg Aug 2024 · Exp Jul 2026 | Ultra Drugs Pvt. LtdHimachal Pradesh | Failed Description (Spots)Description | DTL, PuducherryState lab |
| Levocetirizine Hydrochloride & Montelukast Sodium Suspension(LEMONT KID) | Batch VS2538Mfg Oct 2025 · Exp Sep 2027 | Vertex Pharma ChemicalsPuducherry | Failed Description and assay (For Levocetirizine hydrochloride) & Incorrect LabellingAssay | DTL, PuducherryState lab |
| Levocetirizine & Montelukast Tablets IP | Batch TGT25-156Mfg Jul 2025 · Exp Jun 2027 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua Jammu and KashmirState lab |
| Levocetirizine Tablets IP 5mg Levocet | Batch GT23624CMfg Jul 2023 · Exp Jun 2026 | Hetero Healthcare Ltd. Alldc Industrial Growth Centre ChangsariAssam | DescriptionDescription | FDAL, MumbaiState lab |
| Levocetirizine Dihydrochloride & Montelukast Sodium Tablets IP | Batch LT-25029Mfg Sep 2025 · Exp Aug 2027 | YL PharmaHimachal Pradesh | The sample does not HP conform to the IP with respect to Assay.Assay | DTL, JaipurState lab |
| Levocetirizine Dihydrochloride & Montelukast Tablets 11 | Batch TR25C042CMfg Mar 2025 · Exp Feb 2027 | Rhombus Pharma Pvt. LtdGujarat | The sample does not conmorm to the IP with respect to Assay of Lexncetirizine Dihydrochloride & MoptelukasAssay | DTL JodhpurState lab |
| Levocetirizine Dihydrochloride Tablets | Batch YLT25023Mfg Mar 2025 · Exp Feb 2027 | YL PharmaHimachal Pradesh | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Levetiracetam Tablets IP 500 mg Epivell-500 Tablets | Batch GT5F136Mfg Jun 2025 · Exp May 2027 | Ritual Drugs Pvt. LtdHaryana | The sample received does not conform to I.P. 2022 specification with respect to The test for Dissolution only.Dissolution | CDTL-HyderabadCDSCO lab |
| Levetiracetam Tablets IP 500 mg | Batch LTH2505Mfg Sep 2025 · Exp Aug 2027 | Applied Communication & ControlsUttarakhand | The sample does not conform to claim as per IP 2022 in respect to The Test of Dissolution.Dissolution | RDTL, ChandigarhCDSCO lab |
| LEVTARY - 500 | Batch AA250585AMfg Jul 2025 · Exp Jun 2027 | Gufic Biosciences Limited N.H.No. 08 KabilporeGujarat | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Free drugOther | RDTL, ChandigarhCDSCO lab |
| Itraconazole Capsules BP 200 mg | Batch R08GC2506AMfg Aug 2025 · Exp Jul 2027 | Rednex Pharmaceuticals Pvt. LtdKerala | The sample received does not conform to I.P. 2022 with respect to The test for Dissolution.Dissolution | CDTL, MumbaiCDSCO lab |
| Iodine Tincture IP 66 | Batch IT251Mfg Aug 2025 · Exp Jul 2027 | Apex Healthcare | AssayAssay | DTL, JaipurState lab |
| Ibuprofen and Paracetamol Suspension SNEFLAM DS SUSPENSION, 60 ml | Batch L25J001Mfg Oct 2025 · Exp Sep 2027 | Snehal Pharma & Surgicals Pvt. Ltd. B-1/11Maharashtra | The sample does not conform to claim with respect to The test for Microbial contamination (Test of Total Aerobic Viable Count)Microbial limits | CDTL, MumbaiCDSCO lab |
| ITRAZIL-200 | Batch HA237Mfg Feb 2025 · Exp Jan 2027 | Trio Lifescience Private LtdGujarat | The sample received does not conform to The manufacture's specification with respect to The test for pH.pH | CDTL, MumbaiCDSCO lab |
| Hydroxyzine Oral Solution I.P. | Batch HO1LF002Mfg Jun 2025 · Exp May 2027 | Unicure India LtdUttarakhand | The sample does not conform to claim as per IP 2022 in respect to The test of Related SubstanceRelated substances | CDL, KolkataCDSCO lab |
| Hydroxychloroquine Sulphate Tablets IP 200mg (Auto Q-200) | Batch 308225004Mfg Jul 2025 · Exp Jun 2027 | Regenix Drugs Ltd | Uniformity of weightUniformity of weight/content | Drugs Testing Laboratory, Madurai -19State lab |
| Glycerin IP | Batch 3F/RG/24/0054Mfg Nov 2024 · Exp Oct 2029 | 3F Industries Ltd. 1604Andhra Pradesh | The sample received does not conform to I.P. 2022 with respect to The test for Aldehydes.Other | CDTL, MumbaiCDSCO lab |
| Glipizide and Metformin Tablets USP | Batch URDT0328Mfg Jan 2023 · Exp Dec 2025 | Unicure India LtdUttarakhand | The sample does not conform to the IP with respect to Dissolution of Glipizide.Dissolution | DTL UdaipurState lab |
| Gentamicin Injection IP 2ml | Batch 683508Mfg May 2025 · Exp Apr 2027 | Zazen Pharma Pvt. Ltd | pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Expecotrant, Bronchodilator, Mucolytic(Spair) | Batch LPA-5071Mfg Jul 2025 · Exp Jun 2027 | Spinka PharmaTelangana | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Eucalyptus Oil IP | Batch 654Mfg Oct 2025 · Exp Sep 2027 | Repacked by Ganesh Eucalyptus Oil Disitillery | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Esomeprazole (EC) & Itopride Hydrochloride Capsule | Batch PGC25-08Mfg Mar 2025 · Exp Feb 2027 | Plena Remedies | The sample does not conforms to the claim with respect to Assay of EsomeprazoleAssay | DTL, UdaipurState lab |
| Enteric Coated Rabeprazole Sodium & Domperidone Sustained release Capsules Rabizole - DSR | Batch SPK 1386Mfg Nov 2024 · Exp Oct 2026 | Spanker Biotech LtdHimachal Pradesh | The sample does not conform to Manufacturers Specification with respect to The Test of Dissolution of Rabeprazole Sodium and Assay of Rabeprazole Sodium.Assay | CDL, KolkataCDSCO lab |
| Drotaverine HCl Suspension PED-DS suspension 60ml | Batch L-250901Mfg Sep 2025 · Exp Aug 2030 | Dr. Pal'S Pharmaceuticals 10B-1Uttarakhand | The sample does not conform to claim with respect to The test for Microbial contamination (Total Aerobic Viable Count and Total Fungal Count).Microbial limits | CDTL, MumbaiCDSCO lab |
| Diclofenac Sodium, Paracetamol & Chlorzoxazone Tablets Diclotrum-MR | Batch SGT-231863Mfg Jan 2024 · Exp Dec 2025 | Spectrum Formulation Pvt. LtdUttarakhand | The sample does not conform to claim with respect to Description.Description | CDL, KolkataCDSCO lab |
| Diclofenac Potassium Tablets USP(Ark-75 Tablets) | Batch AST-24002Mfg Jun 2024 · Exp May 2027 | Apex Laboratories private ltdTamil Nadu | Misbranded.Misbranded | DCL TelanganaState lab |
| Diclofenac Potassium & Pracetamol Tablets | Batch PCGT-25013Mfg Jan 2025 · Exp Dec 2026 | Pentachem PharmaceuticalHimachal Pradesh | The sample does not conform to the claim with respect to AssayAssay | DTL, JaipurState lab |
| Diclofenac Potassium & Paracetamol Tablets (MUSCARE-P TAB.) | Batch YLT25027Mfg Jul 2025 · Exp Jun 2027 | YL PharmaHimachal Pradesh | Diclofeanc Potassium Assay 83.54% & Assay Of Paracetamol 79.83%Assay | DTL BADDIState lab |
| Diclofenac Gastro-resistant Tablets I.P. 50 mg | Batch 25T19052Mfg Feb 2025 · Exp Jan 2027 | KRAS Pharmaceuticals Pvt. LtdBihar | The sample does not conform to IP with respect to test for Dissolution in Buffer Stage.Dissolution | CDL, KolkataCDSCO lab |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup (Yokurex D Syrup) | Batch L250320Mfg Mar 2025 · Exp Feb 2027 | SGS Formulation Pvt LtdTamil Nadu | Failed Assay (for Phenylephrine Hydrochloride IP)Assay | DTL, PuducherryState lab |
| Dextromethorphan Hydrobromide, Chlorpheniramine Maleate, Phenylephrine Hydrochloride Syrup(Caredex Junior) | Batch CXR-2502Mfg Jun 2025 · Exp May 2027 | Apple Formulations Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan Hydrobromide, Ambroxol Hydrochloride, Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Menthol Syrup (RespiFresh-AD Cough and Cold Formula) | Batch CLAD4016Mfg Dec 2024 · Exp Nov 2026 | Crest Lifescoences Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan Hydrobromide, Ambroxol Hydrochloride, Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Menthol Syrup (RespiFresh-AD) | Batch CLAD4017Mfg Dec 2024 · Exp Nov 2026 | Crest Lifescoences Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan Hydrobromide, Ambroxol Hydrochloride, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup Tusty Total | Batch OLM24120Mfg Dec 2024 · Exp Aug 2030 | Medishri Healthcare Pvt. LtdUttarakhand | The sample received does not conform to manufacturer specification with respect to The test for Assay of ambroxol hydrochloride content only.Assay | CDTL-HyderabadCDSCO lab |
| Dextromethorphan HBr, Phenylephrine HCI & CPM Syrup(Koff-Max D) | Batch LLD-8030Mfg May 2024 · Exp Apr 2026 | Lifevision HealthcareHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan HBR, Phenylephrine Hydrochloride, & Chlorpheniramine Maleate Syrup (Dexril syrup) | Batch MMR-872Mfg Mar 2025 · Exp Feb 2027 | Mediguard Remedies | Failed Assay (for Phenylephrine Hydrochloride IP)Assay | DTL, PuducherryState lab |
| Dexamethasone Tablets BP 8 mg. Dexarid-8 | Batch RT230508Mfg Jul 2023 · Exp Jun 2026 | Ridley Life Science Pvt. Ltd D-1651Delhi | The sample does not conform to claim as per B.P. 2025 with respect to The test for Assay of Dexamethasone.Assay | RDTL, GuwahatiCDSCO lab |
| Dexamethasone Sodium Phosphate Injection IP 4 mg/ml. DEXOHIN | Batch 69Mfg Jun 2025 · Exp May 2027 | Hindustan Medicines Pvt. Ltd. Barauni-851112 BiharBihar | The sample does not conform to IP with respect to test for Particulate matter and is also not of standard quality for The reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Cyproheptadine, Tricholine and Sorbitol oral solution Cypliv | Batch L25078Mfg Aug 2025 · Exp Jul 2027 | Wamika Pharmaceuticals Private LimitedHaryana | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Sorbitol (70%).Assay | RDTL, ChandigarhCDSCO lab |
| Cotton Bandage | Batch 940Mfg May 2025 · Exp Apr 2027 | Sapna Bunkar Hath Kargha Sahkari Samiti LtdRajasthan | The sample does not conform in respect to The Test of Threads per dm, Weight In Gm/sq.m, Foreign Matter, Fluorescence.Weight | CDL, KolkataCDSCO lab |
| Cotton Bandage | Batch 937Mfg May 2025 · Exp Apr 2027 | Sapna Bunkar Hath Kargha Sahkari Samiti LtdRajasthan | The sample does not conform to The test of weight in Gm/sq.m, threads per dm, Fluorescence, Foreign MatterWeight | CDL, KolkataCDSCO lab |
| Clopidogrel & Aspirin Tablets IP | Batch GT250518Mfg Mar 2025 · Exp Feb 2027 | Theon Pharmaceuticals LtdHimachal Pradesh | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only.Description | CDTL-HyderabadCDSCO lab |
| Clopidogrel & Aspirin Tablets IP | Batch GT250519Mfg Mar 2025 · Exp Feb 2027 | Theon Pharmaceuticals LtdHimachal Pradesh | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only.Description | CDTL-HyderabadCDSCO lab |
| Ciprofloxacin Tablets IP 500mg | Batch 2140Mfg Jan 2023 · Exp Dec 2025 | Hindustan Antibiotics LtdMaharashtra | Failed Description (Rough Surface)Description | DTL, PuducherryState lab |
| Chlorpheniramine Maleate, Dextromethorphan Hydrobromide & Phenylephrine Hydrochloride Syrup(Cofcross Syrup) | Batch LSC-25171Mfg Feb 2025 · Exp Jan 2027 | Prochem Pharmaceuticals Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Chlorpheniramine Maleate & Phenylephrine Hcl Syrup I.P. Ezicold Syrup 60ml | Batch L3126Mfg Sep 2025 · Exp Aug 2027 | Camper HealthcareGujarat | The sample received does not conform to I.P. 2022 with respect to The test of Assay of Phenylephrine Hydrochloride.Assay | CDTL, MumbaiCDSCO lab |
| Ceftriaxone & Sulbactam for Injection IP (Keftragard-1500) | Batch KPD034021AQMfg Jul 2024 · Exp Jun 2026 | Ipca Laboratories LtdUttarakhand | MisbrandedMisbranded | SDTL Raipur ChhattisgarhState lab |
| Cefpodoxime Proxetil Dispersible Tablets 200 mg (Cefonsa-200 DT Tablets) | Batch MVT-749Mfg Sep 2024 · Exp Aug 2026 | Bonn Schtering Bio SciencesPuducherry | Dissolution and Misbranded.Dissolution | DCL TelanganaState lab |
| Cefixime & Lactic Acid Bacillus Tablets Medisefix - 200 LB | Batch DBT138AMfg Oct 2023 · Exp Sep 2026 | Digital Vision 176Himachal Pradesh | The sample does not conform to claim with respect to The Assay of Cefixim and Lactic Acid Bacillus.Assay | CDL, KolkataCDSCO lab |
| Cefixime & Azithromycin, Lactic Acid Bacillus Tablets(ARRCEF- AZ) | Batch 2827Mfg May 2025 · Exp Apr 2027 | MLARRX Pharmaceuticals No 18 Gopalakrishanan Raod T Nagar Chennai 600017Tamil Nadu | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Cefixime & Azithromycin with Lactic Acid Bacillus Tablets (G-CEF- AZ) | Batch GB-2440Mfg Nov 2024 · Exp Oct 2026 | MG - Biotech Pvt. LtdHimachal Pradesh | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Calcium and Vitamin D3 Tablets IP | Batch BCB01AAAMfg Jan 2025 · Exp Dec 2026 | Akums Drugs & Pharmaceuticals Ltd | The sample does not conform to the IP with respect to Assay Vitamin D3Assay | DTL, JaipurState lab |
| Calcium Carbonate & Vitamin D3 Tablets (Nemical) | Batch SBT-2179Mfg Apr 2025 · Exp Sep 2026 | Sterlife Biotech Pvt.LtdGujarat | Sample does not conform to IP with respect to Dissolution and Assay of Vitamin D3Assay | DTL Thrissur,KeralaState lab |
| Calcium & Vitamin D3 Tablets IP (500 mg/250IU) | Batch CDA-583Mfg Mar 2025 · Exp Feb 2027 | Healers Lab Unit IIHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Calcium.Dissolution | RDTL, GuwahatiCDSCO lab |
| Bromhexine Hydrochloride,Terbutaline Sulphate,Guaiphenesin & Menthol Syrup Respifresh-TR | Batch R12GL2426Mfg Dec 2024 · Exp Nov 2026 | Rednex Pharmaceuticals Pvt. LtdKerala | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act in respect to The Assay of Menthol.Assay | CDL, KolkataCDSCO lab |
| Basm Multi-Spectrum Expectorant | Batch MBM 18Mfg Sep 2025 · Exp Aug 2027 | Medline Pharmaceuticals Pvt LtdTamil Nadu | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Atorvastatin Tablets IP 20mg | Batch CT24250048Mfg Apr 2024 · Exp Mar 2026 | CMG Biotech Pvt. Ltd | Assay and Dissolution testAssay | SDT&RL, BhubaneswarState lab |
| Atorvastatin Tablets IP 10mg (Atorwal-10) | Batch IC434002Mfg Feb 2024 · Exp Jan 2026 | Innova Captab Ltd. 81-B EPIPHimachal Pradesh | Assay & Dissolution testAssay | SDT&RL, BhubaneswarState lab |
| Amoxycillin Potassium Clavulanate & Lactic Acid Bacillus Tablets IP | Batch GCA012Mfg Apr 2025 · Exp Mar 2027 | GC HealthcareHimachal Pradesh | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP(CLAVAM 625) | Batch 25441325Mfg Apr 2025 · Exp Sep 2026 | Alkem Health ScienceSikkim | The sample does not conform to standard quality in respect of the test for Dissolution of Amoxycillin performed.Dissolution | SDTL, Govt. of Tripura, Agartala. State- TripuraState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP(Amoxheal ? 625) | Batch ACAA24149CMfg Jan 2025 · Exp Jun 2026 | J.M. LaboratoriesHimachal Pradesh | The sample does not conform to standard quality in respect of the test for Dissolution & Assay of Amoxycillin performed.Assay | SDTL, Govt. of Tripura, Agartala. State- TripuraState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP (500mg+125mg), (Symbiotik XL-625) | Batch SH255011Mfg May 2025 · Exp Apr 2027 | Sotac Healthcare Private LimitedGujarat | Sample fails the tests Dissolution for Amoxycillin and Clavulanic Acid and Assay of Clavulanic Acid.Assay | RDTL Ernakulam,KeralaState lab |
| Amoxycilin, Clavulanic Acid (Kaiclav-625 LB) | Batch ABT24350Mfg Oct 2024 · Exp Mar 2026 | Alexa PharmaceuticalsHimachal Pradesh | Content of Amoxycillin and Clavulanic acidOther | SDT&RL, BhubaneswarState lab |
| Amlodipine Tablets I.P. 2.5 mg | Batch 424-1522Mfg Aug 2024 · Exp Jul 2026 | Zee Laboratories 47Himachal Pradesh | The sample is not of standard quality for The reason stated under Description of The tablets.Description | RDTL, GuwahatiCDSCO lab |
| Amlodipine Besylate and Atenolol Tablets(Amlobact AT) | Batch ABAT-035Mfg Nov 2024 · Exp Apr 2027 | IOSIS Remedies Pvt LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Amitriptyline Hydrochloride Tablets IP 25mg | Batch ATJ-06Mfg Nov 2023 · Exp Oct 2026 | Argon Remedies Pvt. LtdUttarakhand | Failed Description (Capping & Cracking)Description | DTL, PuducherryState lab |
| Amikacin Sulphate Injection I.P. Mikabenz 500 | Batch SVI-24070Mfg May 2024 · Exp Apr 2026 | Sunvet HealthcareHimachal Pradesh | The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for The reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Amikacin Injection IP 100 mg | Batch LI25292Mfg Sep 2025 · Exp Aug 2027 | Agron Remedies Pvt. Ltd. SarverkheraUttarakhand | The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for The reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Ambroxol,Terbutaline,Guaiphenesin and Menthol syrup AMBROLET-LS | Batch OS-12095Mfg Sep 2025 · Exp Aug 2027 | Omnison Pharma Pvt. Ltd. G-456 | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Total yeast and mould count.Other | RDTL, ChandigarhCDSCO lab |
| Ambroxol Hydrochloride. Levosalbutamol Sulphate and Guaiphenesin syrup (Brokuff LS Junior Syrup) | Batch BKJ-2503Mfg Apr 2025 · Exp Mar 2027 | Apple Formulations Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Ambroxol Hydrochloride, Terbutnline Sulphate, Guaiphensesin & Menthol Syrup | Batch BS25061Mfg Jun 2025 · Exp May 2027 | B.Sharda LifescienceGujarat | The sample does not conform to the Claim with respect to Assay Ambroxol Hdyrochloride Menthol and DEG.Assay | DTL, JaipurState lab |
| Ambroxol Hydrochloride, Terbutalline Sulphate, Guaiphenesin & Menthol Syrup(soltus TS) | Batch BL-14Mfg Jun 2025 · Exp May 2027 | Boffin Biotech Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup Wamicof-AX Expectorant | Batch L25082Mfg Sep 2025 · Exp Aug 2027 | Wamika Pharmaceuticals Private LimitedHaryana | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Terbutaline SulphateAssay | RDTL, ChandigarhCDSCO lab |
| Ambroxol Hydrochloride, Guaiphenesin and Levosalbutamol Syrup Corun-LA Junior Syrup | Batch A20497BMfg Mar 2025 · Exp Feb 2027 | Aspen LifesciencesPunjab | The sample does not conform to claim as per Manufacturer's Specification with respect to Assay of Ambroxol Hydrochloride.Assay | CDL, KolkataCDSCO lab |
| Ambroxol Hydrochloride I.P-15.0mg Terbutaline Sulphate I.P-1.25mg Guaiphenesin I.P 50.0mg Menthol I.P -2.5mg GBS JUNIOR | Batch 25L06Mfg Feb 2025 · Exp Jan 2028 | Oro Pharmaceuticals Pvt LtdOdisha | The sample does not conform to claim with respect to Assay of Menthol.Assay | CDL, KolkataCDSCO lab |
| Ambroxol HCI, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup(Coftant Syrup) | Batch AMS25D258Mfg Aug 2025 · Exp Jul 2027 | Alop Medi-Sciences Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Albendazole Tablets IP 400mg | Batch 370725001Mfg Aug 2025 · Exp Jul 2028 | Ravenbhel Healthcare Pvt. LtdJammu & Kashmir | Sample fails the test Dissolution as specified in the Laboratory Protocol as per IP.Dissolution | DTL Thiruvananthapuram,KeralaState lab |
| Albendazole Tablets IP 400 mg | Batch AAO-2502Mfg Apr 2025 · Exp Mar 2027 | Apple Formulations Pvt. LtdUttarakhand | Assay (Albendazole)Assay | SDTL, GuwahatiState lab |
| Albendazole Tablets IP 400 mg | Batch MT250971Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | Batch MT250990Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | Batch MT250998Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | Batch MT250987Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | Batch MT250981Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | Batch MT250989Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | Batch MT251010Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablet IP | Batch PGT24347Mfg Jun 2024 · Exp May 2027 | Affy ParenteralsHimachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to The Test of DissolutionDissolution | RDTL, ChandigarhCDSCO lab |
| Albendazole Oral Suspension IP ALBEND | Batch LBS-006/25Mfg Oct 2025 · Exp Sep 2028 | Drakt InternationalWest Bengal | The sample does not conform to I.P. with respect to The Assay of Albendazole.Assay | CDL, KolkataCDSCO lab |
| Agtha-LS Cough Syrup | Batch UF2674717HMfg Sep 2024 · Exp Aug 2026 | Ultra Drugs Formulations Pvt LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets Getwalk-SP) | Batch SSPT-01929Mfg Jun 2024 · Exp May 2027 | Savya Pharmaceuticals | The sample does not conform to the claim with respect to Assay of Aceclofenac.Assay | DTL, JaipurState lab |
| Aceclofenac Tablets IP 100mg | Batch M25800001Mfg Apr 2025 · Exp Mar 2027 | Dr.Miltons Laboratories Private LimitedPuducherry | Break up of TabletsOther | Drugs Testing Laboratory, Chennai-06State lab |
| Aceclofenac & Paracetamol Tablets(Editrak Tablets) | Batch GVP2504Mfg Sep 2025 · Exp Aug 2027 | Glatrix biotech Pvt.LtdTelangana | Misbranded.Misbranded | DCL TelanganaState lab |
| Aceclofenac & Paracetamol Tablets (Floxy-P) | Batch GT-10033Mfg Sep 2025 · Exp Aug 2027 | Gag Pharmaceuticals | Dissolution and MisbrandedDissolution | SDTL, PunjabState lab |
| Aceclofenac & Paracetamol Tablets | Batch 0069Mfg Oct 2024 · Exp Sep 2026 | Hindustan Antibiotics Ltd PimpriMaharashtra | Failed Assay (for Aceclofenac IP) & Incorrect labellingAssay | DTL, PuducherryState lab |
| Aceclofena? Paracetamol & Serratiopeptidase Tablets | Batch RT2506062Mfg Jun 2025 · Exp May 2027 | Shri Ramesh Industry Pvt LtdHimachal Pradesh | The sample does not conform to the claim with respect to in Assay.Assay | DTL, JaipurState lab |
| (Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup)(Cafact-LS) | Batch EPL-009Mfg Feb 2025 · Exp Jan 2027 | Elixia pharmaceuticals | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| (Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup)(Respolite-D) | Batch SR 080Mfg Dec 2024 · Exp Nov 2026 | Sresan Pharmaceutical ManufacturerKarnataka | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| (Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup)(Medcof Cough Syrup) | Batch GE 127Mfg Aug 2025 · Exp Jul 2027 | Acmey Inc | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| (Acebrophylline, Terbutaline Sulphate & Guaiphenesin Syrup) (Sputnix -AB) | Batch AMS25D051Mfg Feb 2025 · Exp Jan 2027 | Alop Medi-Sciences Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| (CHYMORAL FORTE) Trypsin-Chymotrypsin Tablets | 2KU6L012 | Under Investigation | Food & Drugs Laboratory, Vadodara | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| (Montina-L Tablets) Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP | SPJ241236 | Under Investigation | RDTL,Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SP | FND072001BH | Ipca Laboratories Ltd. 393/394, Melli Jorethang Road, Gom Block, Bharikhola, South District, Sikkim 737 121 | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETS | FND0725001BH | Ipca Laboratories Ltd. 393/394, Melli Jorethang Road, Gom Block, Bharikhola, South District, Sikkim 737 121 | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Telma-AM Telmisartan 40 mg and Amlodipine 5 mg Tablets IP | 05241038A | Under Investigation | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Telma 40 Telmisartan Tablets I.P. 40 mg | 18240413 | Under Investigation | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Telma-AM Telmisartan 40mg and Amlodipine 5 mg Tablets IP | 18240626 | Under Investigation | FDAL, Mumbai | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Deflazacort Tablets 6 mg Defcort 6 | 13240334A | Macleods Pharmaceuticals Ltd. 367/7, Kabra Industrial Estate, Kachigam, Daman 396 210 (U.T.) | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Chymoral Forte Trypsin-Chymotrypsin Tablets | 2KU6L045 | Under Investigation | FDAL, Mumbai | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| (Pantop-D SR) Pantoprazole Sodium Gastro-resistant and Domperidone Prolonged -release Capsules IP | SPA250021 | Under Investigation | RDTL,Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (175 rows). Revised CDSCO lists are diffed on each monthly rebuild.